title: Pharmacologic management of osteoporosis.
abstract: Osteoporosis is a serious health problem of endemic proportions in the United States. Approximately 50% of women will experience an osteoporosis-related fracture during their lifetimes. With the increase in the population of women age 65 and older, nurses need to be familiar with osteoporosis risks, prevention strategies, and screening guidelines to promote well-woman care. We provide an overview of the medications approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis.
authors: Holly B
authors: HB
authors: Fontenot
authors: Allyssa L
authors: AL
authors: Harris
mesh_terms: D015502:Absorptiometry, Photon; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density / Q000502:physiology; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy / Q000379:methods; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000517:prevention & control; D058866:Osteoporotic Fractures / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D011379:Prognosis; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D050071:Bone Density Conservation Agents
keywords: medications; osteoporosis; pharmacology; postmenopausal